Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jinghua Yan

Showing results (131-140 of 161) with videos related to

Pageof 17
Sort By:
European Journal of Immunology|May 18, 2013
Conserved epitopes dominate cross-CD8+ T-cell responses against influenza A H1N1 virus among Asian populationsJun Liu, Bin Wu, Shihong Zhang, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 18, 2020
Cross-species recognition of SARS-CoV-2 to bat ACE2Kefang Liu, Shuguang Tan, Sheng Niu, et al.
Antiviral Research|November 29, 2016
Passive immunotherapy for Middle East Respiratory Syndrome coronavirus infection with equine immunoglobulin or immunoglobulin fragments in a mouse modelYongkun Zhao, Chong Wang, Boning Qiu, et al.
Cell Discovery|October 6, 2020
Broad host range of SARS-CoV-2 and the molecular basis for SARS-CoV-2 binding to cat ACE2Lili Wu, Qian Chen, Kefang Liu, et al.
Cell|May 14, 2019
Molecular Basis of Arthritogenic Alphavirus Receptor MXRA8 Binding to Chikungunya Virus Envelope ProteinHao Song, Zhennan Zhao, Yan Chai, et al.
Journal of Virology|January 5, 2018
Recombinant Chimpanzee Adenovirus Vaccine AdC7-M/E Protects against Zika Virus Infection and Testis DamageKun Xu, Yufeng Song, Lianpan Dai, et al.
Cell Reports|January 10, 2019
Double Lock of a Human Neutralizing and Protective Monoclonal Antibody Targeting the Yellow Fever Virus EnvelopeXishan Lu, Haixia Xiao, Shihua Li, et al.
Cell Reports|October 26, 2018
Limited Cross-Linking of 4-1BB by 4-1BB Ligand and the Agonist Monoclonal Antibody UtomilumabYan Li, Shuguang Tan, Chang Zhang, et al.
Antimicrobial Agents and Chemotherapy|May 11, 2021
Tolerability, Safety, Pharmacokinetics, and Immunogenicity of a Novel SARS-CoV-2 Neutralizing Antibody, Etesevimab, in Chinese Healthy Adults: a Randomized, Double-Blind, Placebo-Controlled, First-in-Human Phase 1 StudyXiaojie Wu, Nanyang Li, Guoqin Wang, et al.
Cell|July 10, 2020
A Universal Design of Betacoronavirus Vaccines against COVID-19, MERS, and SARSLianpan Dai, Tianyi Zheng, Kun Xu, et al.
Pageof 17

Showing results (131-140 of 161) with videos related to

Sort By:
Pageof 17
European Journal of Immunology|May 18, 2013
Conserved epitopes dominate cross-CD8+ T-cell responses against influenza A H1N1 virus among Asian populationsJun Liu, Bin Wu, Shihong Zhang, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 18, 2020
Cross-species recognition of SARS-CoV-2 to bat ACE2Kefang Liu, Shuguang Tan, Sheng Niu, et al.
Antiviral Research|November 29, 2016
Passive immunotherapy for Middle East Respiratory Syndrome coronavirus infection with equine immunoglobulin or immunoglobulin fragments in a mouse modelYongkun Zhao, Chong Wang, Boning Qiu, et al.
Cell Discovery|October 6, 2020
Broad host range of SARS-CoV-2 and the molecular basis for SARS-CoV-2 binding to cat ACE2Lili Wu, Qian Chen, Kefang Liu, et al.
Cell|May 14, 2019
Molecular Basis of Arthritogenic Alphavirus Receptor MXRA8 Binding to Chikungunya Virus Envelope ProteinHao Song, Zhennan Zhao, Yan Chai, et al.
Journal of Virology|January 5, 2018
Recombinant Chimpanzee Adenovirus Vaccine AdC7-M/E Protects against Zika Virus Infection and Testis DamageKun Xu, Yufeng Song, Lianpan Dai, et al.
Cell Reports|January 10, 2019
Double Lock of a Human Neutralizing and Protective Monoclonal Antibody Targeting the Yellow Fever Virus EnvelopeXishan Lu, Haixia Xiao, Shihua Li, et al.
Cell Reports|October 26, 2018
Limited Cross-Linking of 4-1BB by 4-1BB Ligand and the Agonist Monoclonal Antibody UtomilumabYan Li, Shuguang Tan, Chang Zhang, et al.
Antimicrobial Agents and Chemotherapy|May 11, 2021
Tolerability, Safety, Pharmacokinetics, and Immunogenicity of a Novel SARS-CoV-2 Neutralizing Antibody, Etesevimab, in Chinese Healthy Adults: a Randomized, Double-Blind, Placebo-Controlled, First-in-Human Phase 1 StudyXiaojie Wu, Nanyang Li, Guoqin Wang, et al.
Cell|July 10, 2020
A Universal Design of Betacoronavirus Vaccines against COVID-19, MERS, and SARSLianpan Dai, Tianyi Zheng, Kun Xu, et al.
Pageof 17